gvtcx

Proprietary Drugs

eTenderwales Published 28 Jul 2025 Find a Tender

key details

Value£392,774,896
Statuscomplete
Category (CPV) 33600000
RegionWales
Deadline15 Nov 2024
Procedureopen
OCIDocds-h6vhtk-04ac47

Awards (72)

This procurement was awarded to 72 suppliers. Values shown are per-award; the notice total is £392,774,896.

SupplierValueDateStatus
Abbvie Limited shared · · active
Accord UK Limited shared · · active
Alliance Pharmaceuticals Limited shared · · active
Amarox shared · · active
Amicus Therapeutics UK Operations Ltd shared · · active
AMO United Kingdom Ltd shared · · active
Aspen Pharmacare UK Limited shared · · active
Aspire Pharma Ltd shared · · active
Astellas Pharma Ltd shared · · active
Astra Zenica shared · · active
Baxter Healthcare Limited shared · · active
Bayer Plc shared · · active
Biogen Idec Limited shared · · active
Camurus AB shared · · active
Chiesi Limited shared · · active
Chugai Pharma UK Ltd shared · · active
Cipla EU Limited shared · · active
Colonis Pharma Ltd shared · · active
CST Pharma shared · · active
Dr Falk Pharma UK Ltd shared · · active
Dr Reddy's Laboratories (UK) Ltd shared · · active
Eisai Limited shared · · active
Eli Lilly & Company Ltd shared · · active
Essential Pharma shared · · active
Esteve Pharmaceuticals shared · · active
Ferring Pharmaceuticals Ltd shared · · active
Flynn Pharma Ltd shared · · active
Focus Pharmaceuticals Ltd shared · · active
Galen Limited shared · · active
Gedeon Richter shared · · active
Glaxo Smithkline shared · · active
Glenmark Pharmaceuticals shared · · active
IBSA Pharma Ltd shared · · active
Ipsen Limited shared · · active
Janssen Limited shared · · active
Juvise Pharmaceuticals shared · · active
Kent Pharmaceuticals shared · · active
Kyowa Kirin International UK Newco Ltd shared · · active
Lupin Healthcare (UK) Limited shared · · active
Luye Pharma Ltd shared · · active
Martindale shared · · active
Mercury Pharmaceuticals Ltd shared · · active
Merz Pharma UK Ltd shared · · active
Morningside Pharmaceuticals Limited shared · · active
Napp Pharmaceutical Group Ltd shared · · active
Neon Healthcare Ltd shared · · active
Novartis Pharmaceuticals UK Limited shared · · active
Novo Nordisk Pharmaceuticals Ltd shared · · active
Organon Pharma (UK) Limited shared · · active
Orion Pharma UK Ltd shared · · active
Orphalan shared · · active
Otsuka Pharmaceuticals (UK) Ltd shared · · active
Pfizer Limited shared · · active
Provepharm UK Ltd shared · · active
Qdem Pharmaceuticals shared · · active
Rayner Pharmaceuticals Ltd shared · · active
Reckitt Benckiser Healthcare shared · · active
Ridge Pharma shared · · active
Roche Products Ltd shared · · active
Sandoz Ltd shared · · active
Sanofi shared · · active
Sun Pharma UK Ltd shared · · active
Takeda UK Limited shared · · active
Teva UK Ltd shared · · active
Theramex shared · · active
Thornton & Ross Ltd shared · · active
Typharm Ltd shared · · active
UCB Pharma shared · · active
Viatris UK Healthcare Limited shared · · active
Vifor Pharma UK Ltd shared · · active
Wockhardt UK Limited shared · · active
Zentiva Pharma UK Limited shared · · active

description

Proprietary Drugs

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
15 Oct 2024 Contract notice (F02) Earlier regulations 033186-2024
28 Jul 2025 Contract award notice (F03) Earlier regulations 043355-2025

more from eTenderwales

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.